Cargando…
Bamlanivimab for Mild to Moderate COVID-19 in Kidney Transplant Recipients
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233547/ https://www.ncbi.nlm.nih.gov/pubmed/34222731 http://dx.doi.org/10.1016/j.ekir.2021.06.012 |
_version_ | 1783713877007007744 |
---|---|
author | Jan, Muhammad Y. Sayegh, Skye E. Webb, Hanna T. Adebiyi, Oluwafisayo Anderson, Melissa D. Mishler, Dennis P. Yaqub, Muhammad S. Taber, Tim Sharfuddin, Asif A. |
author_facet | Jan, Muhammad Y. Sayegh, Skye E. Webb, Hanna T. Adebiyi, Oluwafisayo Anderson, Melissa D. Mishler, Dennis P. Yaqub, Muhammad S. Taber, Tim Sharfuddin, Asif A. |
author_sort | Jan, Muhammad Y. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8233547 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-82335472021-06-28 Bamlanivimab for Mild to Moderate COVID-19 in Kidney Transplant Recipients Jan, Muhammad Y. Sayegh, Skye E. Webb, Hanna T. Adebiyi, Oluwafisayo Anderson, Melissa D. Mishler, Dennis P. Yaqub, Muhammad S. Taber, Tim Sharfuddin, Asif A. Kidney Int Rep Research Letter Elsevier 2021-06-26 /pmc/articles/PMC8233547/ /pubmed/34222731 http://dx.doi.org/10.1016/j.ekir.2021.06.012 Text en © 2021 International Society of Nephrology. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Letter Jan, Muhammad Y. Sayegh, Skye E. Webb, Hanna T. Adebiyi, Oluwafisayo Anderson, Melissa D. Mishler, Dennis P. Yaqub, Muhammad S. Taber, Tim Sharfuddin, Asif A. Bamlanivimab for Mild to Moderate COVID-19 in Kidney Transplant Recipients |
title | Bamlanivimab for Mild to Moderate COVID-19 in Kidney Transplant Recipients |
title_full | Bamlanivimab for Mild to Moderate COVID-19 in Kidney Transplant Recipients |
title_fullStr | Bamlanivimab for Mild to Moderate COVID-19 in Kidney Transplant Recipients |
title_full_unstemmed | Bamlanivimab for Mild to Moderate COVID-19 in Kidney Transplant Recipients |
title_short | Bamlanivimab for Mild to Moderate COVID-19 in Kidney Transplant Recipients |
title_sort | bamlanivimab for mild to moderate covid-19 in kidney transplant recipients |
topic | Research Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233547/ https://www.ncbi.nlm.nih.gov/pubmed/34222731 http://dx.doi.org/10.1016/j.ekir.2021.06.012 |
work_keys_str_mv | AT janmuhammady bamlanivimabformildtomoderatecovid19inkidneytransplantrecipients AT sayeghskyee bamlanivimabformildtomoderatecovid19inkidneytransplantrecipients AT webbhannat bamlanivimabformildtomoderatecovid19inkidneytransplantrecipients AT adebiyioluwafisayo bamlanivimabformildtomoderatecovid19inkidneytransplantrecipients AT andersonmelissad bamlanivimabformildtomoderatecovid19inkidneytransplantrecipients AT mishlerdennisp bamlanivimabformildtomoderatecovid19inkidneytransplantrecipients AT yaqubmuhammads bamlanivimabformildtomoderatecovid19inkidneytransplantrecipients AT tabertim bamlanivimabformildtomoderatecovid19inkidneytransplantrecipients AT sharfuddinasifa bamlanivimabformildtomoderatecovid19inkidneytransplantrecipients |